160 related articles for article (PubMed ID: 18596838)
21. A novel mutation of the SH3BP2 gene in an aggressive case of cherubism.
Carvalho VM; Perdigão PF; Pimenta FJ; de Souza PE; Gomez RS; De Marco L
Oral Oncol; 2008 Feb; 44(2):153-5. PubMed ID: 17368082
[TBL] [Abstract][Full Text] [Related]
22. Jawing about TNF: new hope for cherubism.
Novack DV; Faccio R
Cell; 2007 Jan; 128(1):15-7. PubMed ID: 17218248
[TBL] [Abstract][Full Text] [Related]
23. A novel mutation in the SH3BP2 gene causes cherubism: case report.
Li CY; Yu SF
BMC Med Genet; 2006 Dec; 7():84. PubMed ID: 17147794
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.
Argyris PP; Gopalakrishnan R; Hu Y; Reichenberger EJ; Koutlas IG
Head Neck Pathol; 2018 Mar; 12(1):136-144. PubMed ID: 28721660
[TBL] [Abstract][Full Text] [Related]
25. [Molecular and Cellular Pathogenesis of Cherubism].
Ueki Y
Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
[TBL] [Abstract][Full Text] [Related]
26. SH3BP2 mutations potentiate osteoclastogenesis via PLCγ.
Lietman SA; Yin L; Levine MA
J Orthop Res; 2010 Nov; 28(11):1425-30. PubMed ID: 20872577
[TBL] [Abstract][Full Text] [Related]
27. A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism.
de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):378-81. PubMed ID: 17321449
[No Abstract] [Full Text] [Related]
28. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.
Ueki Y; Tiziani V; Santanna C; Fukai N; Maulik C; Garfinkle J; Ninomiya C; doAmaral C; Peters H; Habal M; Rhee-Morris L; Doss JB; Kreiborg S; Olsen BR; Reichenberger E
Nat Genet; 2001 Jun; 28(2):125-6. PubMed ID: 11381256
[TBL] [Abstract][Full Text] [Related]
30. DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma.
de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
Br J Oral Maxillofac Surg; 2007 Sep; 45(6):499-500. PubMed ID: 16713042
[TBL] [Abstract][Full Text] [Related]
31. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
Ueki Y; Lin CY; Senoo M; Ebihara T; Agata N; Onji M; Saheki Y; Kawai T; Mukherjee PM; Reichenberger E; Olsen BR
Cell; 2007 Jan; 128(1):71-83. PubMed ID: 17218256
[TBL] [Abstract][Full Text] [Related]
32. Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors.
Wang C; Song Y; Peng B; Fan M; Li J; Zhu S; Bian Z
Oncol Rep; 2006 Mar; 15(3):589-94. PubMed ID: 16465417
[TBL] [Abstract][Full Text] [Related]
33. A c.1244G>A (p.Arg415Gln) mutation in SH3BP2 gene causes cherubism in a Turkish family: report of a family with review of the literature.
Sekerci AE; Balta B; Dundar M; Hu Y; Reichenberger EJ; Etoz OA; Nazlim S; Bayrakdar IS
Med Oral Patol Oral Cir Bucal; 2014 Jul; 19(4):e340-4. PubMed ID: 24608212
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic study of 24 cases of cherubism.
Meng XM; Yu SF; Yu GY
Int J Oral Maxillofac Surg; 2005 Jun; 34(4):350-6. PubMed ID: 16053841
[TBL] [Abstract][Full Text] [Related]
35. RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice.
Kittaka M; Yoshimoto T; Hoffman H; Levitan ME; Ueki Y
Bone Rep; 2020 Jun; 12():100258. PubMed ID: 32258251
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
Ogi K; Nakashima K; Chihara K; Takeuchi K; Horiguchi T; Fujieda S; Sada K
Genes Cells; 2011 Sep; 16(9):951-60. PubMed ID: 21794028
[TBL] [Abstract][Full Text] [Related]
37. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a Norwegian cherubism cohort; molecular genetic findings, oral manifestations and quality of life.
Prescott T; Redfors M; Rustad CF; Eiklid KL; Geirdal AØ; Storhaug K; Jensen JL
Eur J Med Genet; 2013 Mar; 56(3):131-7. PubMed ID: 23298620
[TBL] [Abstract][Full Text] [Related]
39. A comparative immunohistochemical evaluation of CD68 and TRAP protein expression in central and peripheral giant cell granulomas of the jaws.
Torabinia N; Razavi SM; Shokrolahi Z
J Oral Pathol Med; 2011 Apr; 40(4):334-7. PubMed ID: 21029180
[TBL] [Abstract][Full Text] [Related]
40. Clinical and genetic analysis of patients with cherubism.
Machado RA; Pontes H; Pires FR; Silveira HM; Bufalino A; Carlos R; Tuji FM; Alves D; Santos-Silva AR; Lopes MA; Capistrano HM; Coletta RD; Fonseca FP
Oral Dis; 2017 Nov; 23(8):1109-1115. PubMed ID: 28644570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]